Skip to content
PSNL·Nasdaq·US

Personalis

Personalis develops and sells advanced cancer genomic tests, sequencing services, and analytics, including MRD and tumor profiling products. It also provides testing and data services to pharmaceutical companies, research programs, and diagnostic partners.

Thematic Position

PSNL

Relationship Groups

Suppliers1
Customers3
Partners3
Licensing1
Competitors11

Relationship details are part of the Pro plan.

Ended Relationships

4 ended relationships · Ended relationships are part of the Pro plan.

Management Perspective on Regulatory & Geopolitical Developments

state licensingregulatory requirement
State laboratory licensure requirements restrict Personalis testing operations across multiple states
SEC 10-KFeb 26, 2026

The full regulatory passage is part of the Pro plan.

28 more · Regulatory and geopolitical insights are part of the Pro plan.

Disclosed customers above 10% of revenue

1 customer · Named major customers are part of the Pro plan.